Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Capital Expenditures (2018 - 2024)

Dna X filings provide 7 years of Capital Expenditures readings, the most recent being $8000.0 for Q4 2024.

  • On a quarterly basis, Capital Expenditures fell 33.33% to $8000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $214000.0, a 1326.67% increase, with the full-year FY2024 number at $214000.0, up 494.44% from a year prior.
  • Capital Expenditures hit $8000.0 in Q4 2024 for Dna X, down from $137000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $184000.0 in Q1 2020 to a low of -$97000.0 in Q4 2020.
  • Median Capital Expenditures over the past 5 years was $8500.0 (2020), compared with a mean of $19428.6.
  • Biggest five-year swings in Capital Expenditures: tumbled 670.59% in 2020 and later surged 13600.0% in 2024.
  • Dna X's Capital Expenditures stood at -$97000.0 in 2020, then soared by 126.8% to $26000.0 in 2021, then crashed by 92.31% to $2000.0 in 2022, then surged by 500.0% to $12000.0 in 2023, then tumbled by 33.33% to $8000.0 in 2024.
  • The last three reported values for Capital Expenditures were $8000.0 (Q4 2024), $137000.0 (Q3 2024), and $39000.0 (Q2 2024) per Business Quant data.